124 related articles for article (PubMed ID: 10030778)
21. Azithromycin-induced hepatoxicity.
Baciewicz AM; Al-Nimr A; Whelan P
Am J Med; 2005 Dec; 118(12):1438-9. PubMed ID: 16378809
[No Abstract] [Full Text] [Related]
22. Treatment of syphilis with azithromycin.
Mashkilleyson AL; Gomberg MA; Mashkilleyson N; Kutin SA
Int J STD AIDS; 1996; 7 Suppl 1():13-5. PubMed ID: 8652720
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections.
Dey SK; Das AK; Sen S; Hazra A
Indian J Pharmacol; 2015; 47(4):365-9. PubMed ID: 26288467
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
[TBL] [Abstract][Full Text] [Related]
25. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients.
Vaudaux BP; Cherpillod J; Dayer P
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():45-51. PubMed ID: 8818845
[TBL] [Abstract][Full Text] [Related]
26. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls.
Kawamura K; Ichikado K; Suga M; Yoshioka M
Respiration; 2014; 87(6):478-84. PubMed ID: 24802885
[TBL] [Abstract][Full Text] [Related]
28. Sensorineural hearing loss as a probable serious adverse drug reaction associated with low-dose oral azithromycin.
Mick P; Westerberg BD
J Otolaryngol; 2007 Oct; 36(5):257-63. PubMed ID: 17963663
[TBL] [Abstract][Full Text] [Related]
29. [Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome)].
Dietz A; Hübner C; Andrassy K
Laryngorhinootologie; 1998 Feb; 77(2):111-4. PubMed ID: 9555706
[TBL] [Abstract][Full Text] [Related]
30. Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report.
Mamikoglu B; Mamikoglu O
Ann Otol Rhinol Laryngol; 2001 Jan; 110(1):102. PubMed ID: 11201801
[No Abstract] [Full Text] [Related]
31. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children.
Whitty CJ; Glasgow KW; Sadiq ST; Mabey DC; Bailey R
Pediatr Infect Dis J; 1999 Nov; 18(11):955-8. PubMed ID: 10571428
[TBL] [Abstract][Full Text] [Related]
32. Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report.
Shullo MA; Schonder K; Teuteberg JJ
Transplant Proc; 2010 Jun; 42(5):1870-2. PubMed ID: 20620540
[TBL] [Abstract][Full Text] [Related]
33. A case-based approach to evaluating azithromycin use and cardiovascular risks.
Wong E; Nguyen TV
Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
[TBL] [Abstract][Full Text] [Related]
34. Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects.
Wilms EB; Touw DJ; Heijerman HG; van der Ent CK
Pediatr Pulmonol; 2012 Jul; 47(7):658-65. PubMed ID: 22684985
[TBL] [Abstract][Full Text] [Related]
35. Clinical effect of sequential therapy with azithromycin in children mycoplasma pneumoniae pneumonia.
Wang J; Yang C
Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1649-1652. PubMed ID: 30203754
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
37. Potential interaction between azithromycin and warfarin.
Foster DR; Milan NL
Pharmacotherapy; 1999 Jul; 19(7):902-8. PubMed ID: 10417043
[TBL] [Abstract][Full Text] [Related]
38. Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis.
Taylor-Cousar JL; Jain R; Kazmerski TM; Aitken ML; West NE; Wilson A; Middleton PG; Nash EF
J Cyst Fibros; 2021 May; 20(3):395-396. PubMed ID: 32800485
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular death risk linked to azithromycin use.
Kuehn BM
JAMA; 2012 Jun; 307(22):2361. PubMed ID: 22692153
[No Abstract] [Full Text] [Related]
40. Elevated International Normalized Ratio associated with long-term azithromycin therapy in a child with cerebral palsy.
Stork CM; Marraffa JM; Ragosta K; Wojcik SM; Angelino KL
Am J Health Syst Pharm; 2011 Jun; 68(11):1012-4. PubMed ID: 21593229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
